Purple Biotech Ltd Asset Turnover Ratio (PPBT), as of fourth quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Purple Biotech Ltd  (NASDAQ: PPBT)
 

Purple Biotech Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Dec 31 2024, Purple Biotech Ltd has not recorded any assets.
Visit Purple Biotech Ltd Balance sheet

Within sector 263 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2024 compared to the preceding quarter from to 4899.

Asset Turnover Ratio Definition



PPBT Asset Turnover Ratio (Dec 31 2024)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Asset Change -52.56 % 51.98 % -50.52 % -21.98 % -21.98 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) - - - - -
PPBT's Total Ranking # 4899 # # # #
Seq. Asset Change -72.92 % 75.19 % 0 % 0 % -13.25 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 264
Healthcare Sector # 682
Overall Market # 4899

Asset Turnover Ratio Statistics
High Average Low
0.07 0.02 0
  (Dec 31 2024)







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2024 Assets at quarter ending Dec 31 2024



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.